Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

NEW YORK – The US Food and Drug Administration announced Thursday that Cepheid's test for SARS-CoV-2, influenza, and respiratory syncytial virus received Emergency Use Authorization for use in high and moderate complexity laboratories and at the point of care. 

The rapid multiplex RT-PCR test detects and differentiates SARS-CoV-2, influenza A and B, and respiratory syncytial virus RNA and can provide results in 35 minutes. 

The test runs on the company's GeneXpert Dx and GeneXpert Infinity instruments in CLIA-certified moderate and high complexity labs and is indicated for use with nasopharyngeal and nasal swabs and nasal wash/aspirate specimens. The Xpert Xpress SARS-CoV-2/Flu/RSV test runs on the GeneXpert Xpress System at the point of care and is authorized for nasopharyngeal and nasal swabs in CLIA-waived settings.

The Danaher subsidiary announced plans to launch the multiplex test during its second quarter earnings call in July. Cepheid was the first company to receive EUA for a point-of-care test for SARS-CoV-2 in March.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.